Showing results (21-30 of 29) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Journal of Medicinal Chemistry|February 12, 2013
Discovery of 4-{4-[(3R)-3-Methylmorpholin-4-yl]-6-[1-(methylsulfonyl)cyclopropyl]pyrimidin-2-yl}-1H-indole (AZ20): a potent and selective inhibitor of ATR protein kinase with monotherapy in vivo antitumor activityKevin M Foote, Kevin Blades, Anna Cronin, et al.BMJ Open|March 11, 2020
Safetxt: a safer sex intervention delivered by mobile phone messaging on sexually transmitted infections (STI) among young people in the UK - protocol for a randomised controlled trialCaroline Free, Ona L McCarthy, Melissa J Palmer, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 2009
JNJ-26481585, a novel "second-generation" oral histone deacetylase inhibitor, shows broad-spectrum preclinical antitumoral activityJanine Arts, Peter King, Ann Mariën, et al.The Journal of Clinical Investigation|September 26, 2023
The catalytic subunit of DNA-PK regulates transcription and splicing of AR in advanced prostate cancerBeth Adamson, Nicholas Brittain, Laura Walker, et al.Journal of Medicinal Chemistry|March 21, 2007
Pyranone, thiopyranone, and pyridone inhibitors of phosphatidylinositol 3-kinase related kinases. Structure-activity relationships for DNA-dependent protein kinase inhibition, and identification of the first potent and selective inhibitor of the ataxia telangiectasia mutated kinaseJonathan J Hollick, Laurent J M Rigoreau, Celine Cano-Soumillac, et al.Cancer Research|December 24, 2009
AZD8055 is a potent, selective, and orally bioavailable ATP-competitive mammalian target of rapamycin kinase inhibitor with in vitro and in vivo antitumor activityChristine M Chresta, Barry R Davies, Ian Hickson, et al.BMJ (Clinical Research Ed.)|September 28, 2022
Effectiveness of a behavioural intervention delivered by text messages (safetxt) on sexually transmitted reinfections in people aged 16-24 years: randomised controlled trialCaroline Free, Melissa J Palmer, Ona L McCarthy, et al.Journal of Medicinal Chemistry|July 2, 2021
An Alkynylpyrimidine-Based Covalent Inhibitor That Targets a Unique Cysteine in NF-κB-Inducing KinaseIslam Al-Khawaldeh, Mohammed J Al Yasiri, Gregory G Aldred, et al.Cell Chemical Biology|October 21, 2020
Modulating Androgen Receptor-Driven Transcription in Prostate Cancer with Selective CDK9 InhibitorsAndré Richters, Shelby K Doyle, David B Freeman, et al.Pageof 3